Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone vs Montelukast vs Fluticasone/Salmeterol in Asthma
NCT00156819Phase 4Completed
- Sponsor
- Johns Hopkins Center for Clinical Trials and Evidence Synthesis
- Start
- Jun 2003
- Primary completion
- Aug 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial in asthma comparing Fluticasone, Montelukast and Fluticasone plus salmeterol (3 arms). Primary endpoint: Treatment Failure at 16 weeks. Started Jun 2003; status: completed.
02
Drugs
fluticasonemontelukastsalmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00156819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00156819.